Madelaine M. Wohlreich, MD
- 10Articles
- 21.7KReads
- 2003–2009Active
- 32Collaborators
- 76Citations
About
Madelaine M. Wohlreich, MD, has published extensively on the clinical use of duloxetine in the treatment of major depressive disorder, including studies on dosing strategies, efficacy across diverse patient populations, and its effects on associated painful physical symptoms. Her work also addresses the role of duloxetine in fibromyalgia and generalized anxiety disorder, with a focus on both emotional and physical symptomatology. Wohlreich's research spans neurology, depression, and somatoform disorders, contributing to a deeper understanding of pharmacologic interventions in these areas.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
